Literature DB >> 15121769

Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes.

J J McCarthy1, A Parker, R Salem, D J Moliterno, Q Wang, E F Plow, S Rao, G Shen, W J Rogers, L K Newby, R Cannata, K Glatt, E J Topol.   

Abstract

BACKGROUND: to date, only three groups have reported data from large scale genetic association studies of coronary heart disease using a case control design. METHODS AND
RESULTS: to extend our initial report of 62 genes, we present data for 210 polymorphisms in 111 candidate genes genotyped in 352 white subjects with familial, premature coronary heart disease (onset age for men, 45; for women, 50) and a random sample of 418 population based whites. Multivariate logistic regression analysis was used to compare the distributions of genotypes between cases and the comparison group while controlling for age, sex, body mass, diabetes, and hypertension. Significant associations were found with polymorphisms in thrombospondin-4 (THBS4), thrombospondin-2 (THBS2) and plasminogen activator inhibitor-2 (PAI2), the strongest being with the A387P variant in THBS4 (p = 0.002). The THBS2 and THBS4 associations have since been replicated. We evaluated polymorphisms in 40 genes previously associated with coronary heart disease and found significant (p<0.05) associations with 10: ACE, APOE, F7, FGB, GP1BA, IL1RN, LRP1, MTHFR, SELP, and THPO. For five of these genes, the polymorphism associated in our study was different from that previously reported, suggesting linkage disequilibrium as an explanation for failure to replicate associations consistently across studies. We found strong linkage disequilibrium between polymorphisms within and between genes, especially on chromosome 1q22-q25, a region containing several candidate genes.
CONCLUSIONS: despite known caveats of genetic association studies, they can be an effective means of hypothesis generation and complement classic linkage studies for understanding the genetic basis of coronary heart disease.

Entities:  

Mesh:

Year:  2004        PMID: 15121769      PMCID: PMC1579684          DOI: 10.1136/jmg.2003.016584

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  49 in total

Review 1.  Genetic associations in large versus small studies: an empirical assessment.

Authors:  John P A Ioannidis; Thomas A Trikalinos; Evangelia E Ntzani; Despina G Contopoulos-Ioannidis
Journal:  Lancet       Date:  2003-02-15       Impact factor: 79.321

Review 2.  Problems of reporting genetic associations with complex outcomes.

Authors:  Helen M Colhoun; Paul M McKeigue; George Davey Smith
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

3.  Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2.

Authors:  Stephen B Harrap; Kim S Zammit; Zilla Y H Wong; Fiona M Williams; Melanie Bahlo; Andrew M Tonkin; Stanley T Anderson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-05-01       Impact factor: 8.311

4.  The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men.

Authors:  S E Humphries; L A Luong; M S Ogg; E Hawe; G J Miller
Journal:  Eur Heart J       Date:  2001-12       Impact factor: 29.983

5.  Tobacco smoking modifies association between Gln-Arg192 polymorphism of human paraoxonase gene and risk of myocardial infarction.

Authors:  S Sen-Banerjee; X Siles; H Campos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-09       Impact factor: 8.311

6.  [The relationship between angiotensin II type 1 receptor gene and coronary heart disease, hypertension and diabetes mellitus in Chinese].

Authors:  K Xiang; T Zheng; D Sun; J Li
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  1998-02-10

7.  Peroxisome proliferator-activated receptor gamma C161-->T polymorphism and coronary artery disease.

Authors:  X L Wang; J Oosterhof; N Duarte
Journal:  Cardiovasc Res       Date:  1999-12       Impact factor: 10.787

8.  Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde.

Authors:  I Behague; O Poirier; V Nicaud; A Evans; D Arveiler; G Luc; J P Cambou; P Y Scarabin; L Bara; F Green; F Cambien
Journal:  Circulation       Date:  1996-02-01       Impact factor: 29.690

9.  Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden.

Authors:  R E Peacock; A Hamsten; P Nilsson-Ehle; S E Humphries
Journal:  Atherosclerosis       Date:  1992-12       Impact factor: 5.162

10.  A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27.

Authors:  S Francke; M Manraj; C Lacquemant; C Lecoeur; F Leprêtre; P Passa; A Hebe; L Corset; S L Yan; S Lahmidi; S Jankee; T K Gunness; U S Ramjuttun; V Balgobin; C Dina; P Froguel
Journal:  Hum Mol Genet       Date:  2001-11-15       Impact factor: 6.150

View more
  42 in total

1.  Role of FLAP and PDE4D in myocardial infarction and stroke: target discovery and future treatment options.

Authors:  Hakon Hakonarson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

Review 2.  Evaluating HapMap SNP data transferability in a large-scale genotyping project involving 175 cancer-associated genes.

Authors:  Gloria Ribas; Anna González-Neira; Antonio Salas; Roger L Milne; Ana Vega; Begoña Carracedo; Emilio González; Eva Barroso; Lara P Fernández; Patricio Yankilevich; Mercedes Robledo; Angel Carracedo; Javier Benítez
Journal:  Hum Genet       Date:  2005-12-02       Impact factor: 4.132

Review 3.  The genetics of heart attack.

Authors:  Eric J Topol
Journal:  Heart       Date:  2006-06       Impact factor: 5.994

4.  Discovery of biomarker candidates for coronary artery disease from an APOE-knock out mouse model using iTRAQ-based multiplex quantitative proteomics.

Authors:  Linhong Jing; Carol E Parker; David Seo; Maria Warren Hines; Nedyalka Dicheva; Yanbao Yu; Debra Schwinn; Geoffrey S Ginsburg; Xian Chen
Journal:  Proteomics       Date:  2011-06-17       Impact factor: 3.984

Review 5.  Thrombospondin-4 in tissue remodeling.

Authors:  Olga Stenina-Adognravi; Edward F Plow
Journal:  Matrix Biol       Date:  2017-11-11       Impact factor: 11.583

Review 6.  Low-density lipoprotein receptor-related protein-1: role in the regulation of vascular integrity.

Authors:  Dudley K Strickland; Dianaly T Au; Patricia Cunfer; Selen C Muratoglu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-06       Impact factor: 8.311

Review 7.  Nonconventional genetic risk factors for cardiovascular disease.

Authors:  Christopher N Tymchuk; Jaana Hartiala; Pragna I Patel; Margarete Mehrabian; Hooman Allayee
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

8.  Hepatic deficiency of low density lipoprotein receptor-related protein-1 reduces high density lipoprotein secretion and plasma levels in mice.

Authors:  Joshua E Basford; Lauren Wancata; Susanna M Hofmann; R A Gangani D Silva; W Sean Davidson; Philip N Howles; David Y Hui
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

9.  Control of organization and function of muscle and tendon by thrombospondin-4.

Authors:  Ella G Frolova; Judith Drazba; Irene Krukovets; Volodymyr Kostenko; Lauren Blech; Christy Harry; Amit Vasanji; Carla Drumm; Pavel Sul; Guido J Jenniskens; Edward F Plow; Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-03-01       Impact factor: 11.583

10.  Athsq1 is an atherosclerosis modifier locus with dramatic effects on lesion area and prominent accumulation of versican.

Authors:  Sara Bretschger Seidelmann; Chaoling Kuo; Nick Pleskac; Jennifer Molina; Scott Sayers; Rong Li; Jing Zhou; Pamela Johnson; Kathleen Braun; Christina Chan; Daniel Teupser; Jan L Breslow; Thomas N Wight; Alan R Tall; Carrie L Welch
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-25       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.